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Abstract
We compared hospital encounters between adolescents and young adults with fragile X syndrome 
(FXS) to peers with intellectual disability (ID) from other causes, autism spectrum disorder 
(ASD), and a comparison group without these conditions matched by gender, age, and insurance 
coverage. Those with FXS, ASD, or ID were more likely to have had hospital encounters. In terms 
of age groups, we found mental illness hospitalizations decreased during adulthood as compared 
to adolescence for those with FXS, and we found that for conditions unrelated to FXS (e.g., 
respiratory, genitourinary, gastroenteritis, and pneumonia) adolescents had higher rates of 
hospitalization compared to their peers with FXS, ID, or ASD. We analyzed epilepsy, common 
among people with FXS and designated as an ambulatory care sensitive condition that can be 
treated outside the hospital, and found that people with FXS, ID, and ASD had higher odds of 
hospitalization due to epilepsy in both age groups than did the comparison group.
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Fragile X syndrome (FXS) is the most common inherited form of intellectual disability (ID), 
with a reported prevalence of 1/3600–4000 males and 1/4000–6000 females (Coffee et al., 
2009; McLennan, Polussa, Tassone, & Hagerman, 2011; Tarleton & Saul, 1993; Turner, 
Webb, Wake, & Robinson, 1996). In general, males are more severely affected by this 
disorder than females. Most males with FXS have mild to moderate ID, while only about 
one-third of affected females have ID (Belmonte & Bourgeron, 2006; Hagerman & 
Hagerman, 2002; Loesch, Huggins, & Hagerman, 2004). The health care needs of children, 
but not necessarily adults, with FXS have been described in the research literature, and 
guidelines have been established for evaluation, monitoring, and treatment. The guidelines 
emphasize features of FXS, including hypotonia and hypermobile joints, scoliosis, pes 
planus, inguinal hernias, recurrent otitis media and sinusitis, gastro-esophageal reflux, 
strabismus, refraction errors, sleep disturbances, macro-orchidism, cardiac murmur, 
behavioral problems, and epilepsy (Hagerman et al., 2009; Hersh et al., 2011). The literature 
also contains documentation of self-reported health conditions from nonrepresentative 
samples of the adult population with FXS (Bailey et al., 2008; Berry-Kravis et al., 2010; 
Hartley et al., 2011; Raspa, Bailey, Bishop, Holiday, & Olmsted, 2010). Other studies have 
used surveys (Berry-Kravis et al., 2010; Kronk et al., 2010) or clinical record review (Berry-
Kravis, 2002; Musumeci et al., 1999) to confirm comorbid conditions. Since studies that rely 
on self-reporting and clinical record review can be biased, we conducted a literature search 
for studies that examined comorbid conditions and used community or large insurance plans 
for data. We only found a Finnish study that reported no difference in overall cancer 
prevalence between 302 persons with FXS and the rest of the population during a 21-year 
follow-up period (Sund, Pukkala, & Patja, 2009).
FXS is one cause of ID and it is unknown whether the health care utilization of people with 
FXS differs from that of people in the broader category of ID of any cause. In addition, 
although some individuals might have both FXS and autism spectrum disorder (ASD), some 
individuals with FXS may be misdiagnosed as having ASD when delays in development are 
coupled with behavioral issues. The positive diagnosis of FXS relies on a DNA test that 
became available over 20 years ago (Garber, Visootsak, & Warren, 2008). In South 
Carolina, where the current study was conducted, it has been the policy of the South 
Carolina Department of Disabilities and Special Needs (DDSN) to offer free genetic testing 
to anyone who receives services from the agency for ID or ASD to identify the cause of each 
individual’s condition. For those individuals who consented to the DDSN-sponsored genetic 
testing, we were able to confirm whether they were diagnosed with the full mutation FXS; 
however, it is likely that some people with FXS received DDSN services for ID but did not 
elect to be tested, and others with FXS did not receive DDSN services.
The health status of people with ID and/or ASD is affected by comorbid conditions 
associated with their primary disability, the social determinants of health, and the health care 
system. The transition from pediatric to adult health care is one area of concern and the 
issues include reported lapses in care between the last pediatric visit and the first visit with 
an adult health care provider, less guidance with health care decisions from providers upon 
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entering the adult system, reduced access to physicians, longer waiting periods between 
appointments, and reduced coordination between health care professionals (American 
Academy of Pediatrics, 2002; Blum, 2002; Geenen, Powers, & Sells, 2003; Peter, Forke, 
Ginsburg, & Schwartz, 2009; Reiss and Gibson, 2002). The transition has not been 
described for individuals with FXS, but a consensus statement of the American Academy of 
Pediatrics, American Academy of Family Physicians, American College of Physicians, and 
American Society of Internal Medicine, supports the policy of having a written health care 
transition plan in place for all adolescents with special health care needs by the age of 14 
years (American Academy of Pediatrics, 2002). In general, the transition from pediatric to 
adult care for all people is determined on an individual basis, but typically occurs between 
the ages of 18 and 21 (American Academy of Pediatrics, 2011).
The literature on the health and illness experience of adolescents and young adults with FXS 
is limited and does not address emergency department (ED) visits and inpatient 
hospitalizations (IPH), the two types of hospital encounters. The purpose of this study is to 
describe the patterns of hospital encounters among adolescents and young adults with FXS 
using a population-based approach. FXS is a specific cause of ID so the comparison of 
hospital encounters is between adolescents and young adults with FXS and the larger 
independent age-specific groups of people with ID (and no FXS or ASD), those with ASD 
and no ID, and a matched comparison group with none of these conditions. Any IPH that 
originated through the ED was categorized as an IPH to avoid double counting. We 
addressed four hypotheses:
1. Adolescents and young adults with FXS, ASD, or ID have a higher probability of 
encounters with EDs and IPH services when compared to a matched group of 
adolescents and young adults without these conditions.
2. Young adults with FXS have a higher probability of hospital encounters than 
adolescents with FXS.
3. Compared to a matched group of unaffected individuals, hospital encounters are 
more likely in the adolescent and young adult FXS groups for conditions 
previously reported to be more prevalent among people with FXS (e.g., seizures 
and epilepsy; mental illness conditions; neurologic conditions; and ear, nose, and 
throat conditions), though age modifies the difference in the frequency of these 
encounters.
4. There are no differences in the probabilities of hospital encounters between 
individuals with FXS and a comparison group of unaffected individuals for 
ambulatory care sensitive conditions (ACSCs) that are not associated with FXS 
(e.g., bacterial pneumonia, gastroenteritis, genitourinary system conditions, and 
respiratory conditions).
Methods
We used a statewide population-based cross-sectional design to make comparisons about 
hospital encounters between adolescents and young adults with FXS, ASD, or ID and a 
group without these conditions matched by gender, age, and length of insurance coverage. 
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Matching was used to select a comparison group for three reasons: (1) there are differences 
in health care experience by gender and FXS is predominately a male condition, (2) the 
study was designed to document the transition from pediatric to adult medical care and the 
typical age of transfer is 18 years, and (3) insurance coverage influences care patterns. Four 
independent groups of adolescents and young adults were identified as follows: (1) FXS 
(International Classification of Diseases, 9th edition [ICD9] code 759.83), (2) ASD (ICD9 
code 299), (3) other causes of ID (ICD9 codes 317–319), and (4) a matched group free of 
these conditions.
We compared the probability of hospital encounters related to four broad disease categories 
and four selected ACSCs (Ansari, Laditka, & Laditka, 2006). The four broad categories 
included two that were associated with FXS—all mental illness (International Classification 
of Diseases, 9th edition-Clinical Modification [ICD9CM] code 290–319) and all 
neurological conditions (ICD9CM code 320–389)—as well as two that were not associated 
with FXS: all respiratory conditions (ICD9CM code 460–519) and all genitourinary 
conditions (ICD9CM code 580–629). ACSCs are defined as conditions that can be managed 
effectively in the ambulatory setting; therefore, ED visits or IPHs due to these conditions 
may often be attributed to inadequate primary care. The Agency for Healthcare Research 
and Quality (AHRQ) has developed a list of ACSCs, with the acknowledgement that other 
factors outside the direct control of the health care system, such as lack of patient adherence 
to recommendations and environmental conditions, can result in hospitalization (AHRQ, 
2004). The ACSCs that we investigated included epilepsy (ICD9 code 345 and 780.3) and 
conditions of the ear, nose and throat (ICD9 codes 382, 462, 463, 465, 472.1), because they 
are more common in people with FXS (Bailey et al., 2008; Hersh et al., 2011). We also 
included the ACSCs of gastroenteritis (ICD9 code 558.9), and pneumonia (ICD9 codes 481, 
482.2, 482.3, 482.9, 483, 485, 486), which are not specifically linked to FXS. Overall, if 
adolescents and young adults with FXS do not differ from their matched gender, age, and 
similarly insured peers on hospital encounters related to ACSCs, then their outpatient 
primary care and their medical management would be viewed as being as satisfactory as that 
of the general population. Also, if the rate of ED or IPH visits for ACSCs increases between 
the 15–19 years age group and that of the 20–24 years age group, then the transition from 
pediatric to adult care for individuals with FXS would be the suspected cause.
The statewide data used in this study were housed at the South Carolina Budget and Control 
Board’s Division for Research and Statistics (DRS), the central repository for the state’s 
health and human services data. Health encounter data included two insurance sources: 
Medicaid and the State Health Plan. Linkages to the South Carolina Department of Social 
Services (DSS) and the South Carolina Department of Education (SDE) provided additional 
data elements. Through a series of statutes and agreements, agencies and organizations 
entrust their data systems to the DRS while retaining control of their information at all 
times. To “link across” data sources from multiple providers, the DRS developed a series of 
algorithms using source-specific personal identifiers to create global unique identifiers. 
Using global identifiers in lieu of personal identifiers enables staff to protect confidentiality. 
Data usage and linkage approvals for the project were obtained from participating providers 
from whom the data originated. This study is part of a larger project investigating the 
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transition from pediatric to adult services for adolescents and young adults with rare 
conditions. The methods used to merge data across sources for the larger project are 
described in detail in a methods paper (Royer et al., 2014). For this study, we included 
people who were enrolled for all 12 months of each year between 2000 and 2010; often the 
same individuals were included in multiple years as long as they were between the ages of 
15 and 24 years during this period. We used age as a dichotomous variable: adolescents (15–
19 years) and young adults (20–24 years), as the study was designed to analyze the 
transition from pediatric to adult medical care.
Case Identification
People with FXS were identified by searching for ICD9 code 759.83 from a variety of 
electronic sources. We first identified FXS using confirmatory DNA analysis at the 
laboratory that identifies most cases of FXS in South Carolina. These data were provided 
through DDSN and were sent to DRS with a flag indicating a positive result. The second 
approach to identifying FXS involved the search for the ICD9 code in multiple data sources 
among individuals who were 15–24 years old during the time period 2000–2010, inclusive. 
When it was available, we searched administrative data for diagnostic codes when people 
were younger. This was done for all 15–24-year-olds with ID or ASD to determine if they 
had been given an ICD9 code for FXS at younger ages. Thus, we were able to ascertain FXS 
from multiple sources using a number of probing strategies. We required two separate 
instances of FXS coding to identify a case as FXS.
Comparison Groups Identification
To select the two comparison groups of individuals with ASD or ID without FXS, we first 
searched for the ICD9 codes for these conditions in the Medicaid, State Health Plan, and 
Hospital Discharge Dataset (HDDS) files. Due to the fact that many physicians and other 
health care providers often code for the presenting diagnosis and not for any underlying 
disabilities, we also searched previous years in our data sources to identify whether people 
had been coded for ASD or ID earlier in life. Again, we required coding in two separate 
instances to classify someone with ID or ASD, and we excluded those individuals who were 
classified as FXS on two or more occasions, regardless of whether they had ever also been 
coded as having ID and/or ASD. (These excluded individuals were included in the FXS case 
group.) For the remainder of the group, we classified those who were coded with both ID 
and ASD as having ASD, and the rest as having ID.
We obtained the third comparison group from the State Health Plan exclusively, to ensure 
that members of that group did not have any of the three conditions. The State Health Plan 
dataset includes families in which at least one person is working for a local or state agency 
or organization. It does not include information on race; thus, we coded the race variable as 
missing for this comparison group. We selected two individuals without a disability from the 
State Health Plan dataset for each individual with a disability (FXS, ID, or ASD) identified 
in all three datasets, and matched all groups by age, gender, and years of insurance coverage.
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Independent Variables and Model Building
The variables considered from the Medicaid and State Health Plan datasets included the 
ICD9CM primary diagnosis code or the main reason for the ED visit or IPH, as recorded by 
hospital coders; age group; gender; race (if available); and county of residence type 
(dichotomized as urban or rural based on U.S. Census rural-urban commuting area codes). A 
linkage with the SDE provided data on most recent grade level attained and codes for being 
placed in special education services. These codes were assigned according to the Education 
Finance Act (EFA) and include the following categories: Educable Mentally Handicapped, 
Trainable Mentally Handicapped, Profound Mentally Handicapped, Learning Disability 
(which includes Developmentally Delayed and Other Health Impaired), Orthopedically 
Handicapped (which includes Traumatic Brain Injury), ASD, Emotionally Handicapped, 
Hearing Handicapped, and Visually Handicapped. Finally, we obtained data on 
supplemental nutrition assistance (food stamps) from DSS, which we used as a proxy for 
socioeconomic status.
For some individuals studied, there were multiple observations at different ages. Assuming 
that observations from the same person were more alike than observations from different 
people, we used generalized estimating equation (GEE) models to compare the affected 
groups (FXS, ASD, ID) among themselves and to an unaffected comparison group (Hardin 
& Hilbe, 2012; Liang & Zeger, 1986). Logistic GEE models allow analysis of relationships 
between repeated binary outcome models in which, in addition to the main effects of the 
three conditions (FXS, ASD, ID), we included the potential confounders of age group (15–
19 and 20–24 years); race (Caucasian, African American, Other); gender (male, female); 
food stamps enrollment (yes, no); grade 12 attainment or higher (yes, no); placed in special 
education (yes, no); and county type (rural, urban).
Because our interest was to test whether the transition from adolescence to young adulthood 
had any influence on the probability of hospital encounters between condition and 
comparison groups, we added terms to the model for the interaction of each condition with 
each age group. If any interaction term was statistically significant, the key results for 
conditions were reported and stratified by age. Results from our models estimated the odds 
of having a hospital encounter given that the person has the condition versus the odds of 
having a hospital encounter given that the person does not have the condition (odds ratio), 
after adjusting for potential confounders. The adjusted odds ratio was then converted into 
the probability of having a hospital encounter for people with and without the condition. We 
also used the fitted GEE model to estimate adjusted probabilities of hospital encounters for 
each group, controlling for the same confounders as mentioned above. Because the length of 
enrollment in the insurance plans was variable for different individuals, we used person-
years of enrollment to standardize the rates of hospital encounters to a common 
denominator. We used Statistical Analysis System (SAS) 9.3 in all the analyses.
Results
For the period of 2000 to 2010, we selected individuals aged 15 through 24 years, with at 
least 1 year of eligibility for Medicaid or State Health Plan insurance, and we identified 125 
individuals with FXS, 2,592 individuals with ASD, 10,685 with ID, and a comparison group 
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(2 to 1 match) of 26,804 peers unaffected by any of these conditions. Forty-one individuals 
with FXS (32.8%) were confirmed by DNA testing. Table 1 shows the basic characteristics 
of these four groups. The gender-specific prevalence for FXS in our sample was 8.8 per 
10,000 males and 1.9 per 10,000 females, aged 15–24 years in the Medicaid or State Health 
Plan databases with at least 1 year of eligibility. Extrapolating from the 2005 South Carolina 
population (United States Census Bureau, 2005), the gender-specific prevalence in the state 
was 2.8 per 10,000 males and 1.2 per 10,000 females, aged 15–24 years.
In our results, adolescents and young adults with FXS, ASD, and ID were all more likely to 
be male, consistent with the higher prevalence of these conditions in males. Table 1 also 
shows that the proportion of African Americans in our FXS study group was 28%; it was 
about 33% in the group of people with ASD and about 56% of those with ID. For the state 
as a whole, approximately 28% of the population is African American (United States Census 
Bureau, 2005). Also, 68% of those with FXS, 77% of those with ASD, 68% of those with 
ID, and 73% of those in the comparison group lived in urban counties; similarly, 72% of the 
state population lived in urban areas in 2005 (United States Census Bureau, 2005).
To test our first hypothesis, we compared the adjusted probabilities of any hospital 
encounters (ED visits and IPHs) for adolescents and young adults with FXS, ASD, and ID to 
the unaffected comparison group. We found that the adjusted probabilities per person-year 
for those with FXS were 27.1% for adolescents and 18.6% for young adults; for people with 
ASD it was 24.7% for adolescents and 21.8% for young adults; for those with ID it was 
33.8% for adolescents and 32.3% for young adults; and for the unaffected group it was 
14.5% for adolescents and 13.1% for young adults. Overall, the probabilities of hospital 
visits were statistically higher for adolescents and young adults with FXS, ASD, and ID, as 
compared to the unaffected group. Figure 1 shows the adjusted probabilities for the FXS, 
ASD, ID, and comparison groups by type of visit (ED or IPH). The adjusted probability of 
ED visits was higher for adolescents with FXS compared to adolescents in the unaffected 
group (24.1% vs. 13.7%). The adjusted probabilities of ED visits were also higher for young 
adults with FXS versus unaffected young adults (17.0% vs. 12.1%). For the other two 
conditions, ASD and ID, the adjusted rates of ED visits were also higher than the rates in the 
unaffected comparison group for both adolescents (ASD = 21.1%, ID = 29.9%) and young 
adults (ASD = 19.4%, ID = 27.9%). Regarding the probability of IPHs, adolescents with 
FXS, ASD, or ID showed much higher adjusted rates of visits than the unaffected 
comparison group. Among young adults, the group with ID showed a higher probability than 
the comparison group (12.7% vs. 1.5%); although for those with either FXS and/or ASD, the 
probability was close to 7%. Similarly, among adolescents, the probability of IPHs for 
people with any of the conditions (ASD = 10.4%, ID = 11.5%, FXS = 12.8%) was higher 
than it was for the comparison group (1.2%).
Our second hypothesis was that young adults with FXS have higher probabilities of hospital 
encounters (ED visits and IPHs) than do adolescents with FXS. In our study, the overall 
probability of hospital encounters was actually lower for young adults (18.6%) as compared 
to adolescents (27.1%), but the difference was not statistically significant. The probabilities 
for ED visits of adolescents and young adults with FXS were not statistically different either 
(p = 0.0600), with rates of 24.1% and 17.0%, respectively. Similarly, for IPHs of 
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adolescents with FXS versus young adults with FXS, the respective rates were 12.8% and 
7.3%, and the difference was not statistically significant (p = 0.0639).
Table 2 shows the adjusted odds ratios for differences in hospital encounters between 
individuals with FXS, ASD, or ID and confidence intervals relative to a comparison with a 
group of unaffected peers. In general, the odds of an ED visit for adolescents with any of the 
three conditions were between 1.7 and 2.7 times the odds for adolescents without these 
conditions. Except for the odds ratio for young adults with FXS, all of the odds ratios for the 
young adults were statistically significant. Similarly, the odds of an IPH among adolescents 
with FXS, ASD, or ID were between 9.4 and 11.8 times the odds for the comparison group. 
All of these odds ratios were statistically significant for adolescents.
Odds ratios for covariates are not shown in Table 2 but are summarized here. Males had 
increased odds of hospital encounters (p < 0.0001), food stamps enrollment was not 
associated with ED visits, but not attaining grade 12 was associated with higher odds of ED 
visits (p < 0.0001). For IPHs, not attaining grade 12 (p < 0.0001), being male (p < 0.0001), 
living in an urban area (p = 0.0051), and being placed in special education (p < 0.0001) were 
all associated with an increased rate. ED visits did not differ significantly between 
individuals residing in urban versus rural counties.
Our third hypothesis was that, compared to a matched group of unaffected individuals, 
hospital encounters were more frequent in the FXS group for conditions previously reported 
to be more prevalent among people with FXS (e.g., seizures and epilepsy; mental illness 
conditions; neurologic conditions; and ear, nose, and throat conditions), but we expected that 
age would have modified the difference in the frequency of these encounters. This third 
hypothesis was tested concurrently with our fourth hypothesis, which stated that there were 
no differences in the rates of hospital encounters between individuals with FXS and a 
comparison group of unaffected individuals for ACSCs not associated with FXS.
Table 2 displays, for individuals with FXS, the adjusted odds ratios of having had a hospital 
encounter for several types of conditions according to their association with FXS by age. 
Regarding conditions associated with FXS, the odds of an adolescent with FXS to have had 
a hospital encounter related to mental illness were about 108.4 times higher than the odds 
for an individual without FXS. These odds were reduced to 33.2 times for young adults with 
FXS. For this case only, the effect of interaction with age was statistically significant (p = 
0.0101). Also, for an individual with FXS compared to an individual in the comparison 
group, the odds of having had a hospital encounter related to a neurological condition were 
about 5.8 times and 5.6 times the odds for an adolescent and a young adult without FXS, 
respectively. In this case, the interaction with age was not statistically significant. Table 2 
also shows that, for ACSCs, the odds of individuals with FXS to have had a hospital 
encounter related to epilepsy or seizures were much higher than the odds for unaffected 
individuals. As for conditions not associated with FXS, individuals with FXS had higher 
odds of hospital encounters related to genitourinary, gastrointestinal, and respiratory 
conditions than did unaffected individuals. In some cases, the differences were statistically 
significant. The interaction with age was not statistically significant for any of these 
conditions.
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We also calculated the system-specific odds for hospital encounters for people with ID and 
those with ASD. We found that adolescents with ID and ASD had statistically significantly 
higher odds of hospital encounters, compared to young adults with the following conditions: 
all mental illness; all neurological illness; ear, nose, and throat illness; and all respiratory 
illness. The conditions that were not statistically significantly different for the two age 
groups, for either ID or ASD, were epilepsy and genitourinary conditions. However, it 
should be noted that the odds ratio of hospital encounters due to epilepsy for people with 
ASD was 26.8 (95%CI: 14.8–48.8, p < .0001) for 15- to 19-year-olds and 22.4 (95% CI: 
11.87–42.4, p < .0001) for 20- to 24-year-olds when compared to the group with none of the 
conditions. The odds ratio of hospital encounters due to epilepsy for people with ID was 
19.3 (95%CI: 10.5–35.5, p < .0001) for 15- to 19-year-olds and 20.3 (95% CI: 11.1–37.1, p 
< .0001) for 20- to 24-year-olds when compared to the unaffected group. Obviously, these 
odds ratios for hospital encounters reflect the high epilepsy prevalence for these groups.
Figure 2 shows the adjusted rates from the fitted models for the two age groups with FXS. 
The confounders were gender, food stamps, whether the individual attained grade 12, 
whether the individual was placed in special education, the interaction of attaining grade 12 
and receiving special education, and the rural/urban composition of the county of residence. 
Figure 2 also shows the adjusted rates and standard errors when comparing adolescents and 
young adults for a number of hospital encounter types. We found that there was a significant 
difference between the two age groups for all mental illness. We hypothesized that young 
adults with FXS have a higher probability of hospital encounters than adolescents with FXS, 
but our analyses did not demonstrate a significant difference in hospital encounters between 
the two age groups.
Discussion
Using population-based data, we estimated the prevalence of FXS in the general population 
of South Carolina and found that our estimate was comparable to the often-referenced 
estimate of 1/ 3600 (Turner et al., 1996). The prevalence among members of the two 
insurance plans we used in our analyses was higher than estimated for the general 
population, because Medicaid includes a disproportionately high number of people who 
have ID and fewer people without disability in the age groups studied.
This study confirmed our first hypothesis that adolescents and young adults with FXS have 
higher odds of having IPH or ED visits than the comparison group, but the hospitalization 
rates were similar to the groups with ID and ASD. Our second hypothesis, that there would 
be more IPH and ED visits for young adults with FXS as compared to adolescents with FXS, 
was not confirmed, with the exception of people with FXS who required care for mental 
illness. This hypothesis relates to the transition from pediatric to adult medical care, a topic 
that has received substantial attention. It is important to note the IPH odds ratio and mental 
illness hospital use (see Table 2) were statistically significantly higher for adolescents as 
compared to young adults when we controlled for known confounders. The premise of 
concerns about transition is that IPHs will increase after adolescents leave pediatric care; 
however, we found that inpatient stays and combined ED visits and IPHs for mental illness 
were actually higher for adolescents as compared to young adults. We assume this was due 
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to the age of onset of psychiatric conditions, typically occurring during adolescence, 
followed by medication and stabilization during early adulthood. Previous research has 
suggested the possibility that some of these adolescent ED and IPH visits could have been 
prevented if outpatient care during adolescence was intensified (Bindman, Chaltopadhyay, 
Osmond, Huen, & Bacchetti, 2005; Oster & Bindman, 2003); however, this could not be 
investigated using the data from this study. There was no statistically significant difference 
in hospital utilization for adolescents and young adults with FXS for other diagnoses. For 
the segment of the study population that was insured by Medicaid and the State Health Plan, 
it appears that the transition out of pediatrics was not associated with increased risk for IPH 
and ED visits related to ACSCs.
Our third hypothesis, that system-specific visits are more prevalent among people with FXS 
than among the comparison group for conditions reported in the literature as being common 
among those with FXS, was confirmed. All mental illness (OR 108.4: 95% CI 55.4–212.1), 
all neurologic conditions (OR 5.8: 95% CI 2.5–13.3), and the ACSC for seizures/epilepsy 
(OR 36.1: 95% CI 13.9–93.7), were statistically significantly higher for those with FXS, in 
contrast to the comparison group, after controlling for potential confounders. It is well 
established that seizure disorders are more common among people with neurodevelopmental 
disorders, including FXS, ASD, and ID, which could have driven the observed differences in 
ED/IPH utilization rates for those problems (Centers for Disease Control and Prevention, 
2008; Deykin & MacMahon, 1979; Hart & Shorvon, 1995; Kotsopoulos, van Merode, 
Kessels, de Krom, & Knottnerus, 2002; McDermott et al., 2005). We explored the frequency 
of an epilepsy diagnosis among the three groups in our sample, and found that the 
prevalence of any diagnosis of epilepsy was, in fact, substantially higher among those with 
any of the three disabilities (24.8% for FXS, 36.7% for ASD, and 27.1% for ID versus 1.4% 
for the comparison group). The point estimates for the rate of seizures are similar, although a 
little higher, than those noted in the literature (Berry-Kravis et al., 2010; Centers for Disease 
Control and Prevention, 2008; Kotsopoulos et al., 2002; McDermott et al., 2005). The higher 
rate of occurrence is probably the result of misdiagnoses of related neurologic conditions 
such as tic disorders, stereotypes, and medication effects, which could not be clarified using 
the secondary data sources. Nonetheless, optimizing ambulatory care has the potential to 
reduce the need for emergency room treatment and hospitalization in adolescents and young 
adults who have FXS, ASD, or ID and also have a seizure disorder. Clinicians who provide 
care for people with these conditions should focus on finding effective ways to prevent the 
overutilization of emergency or inpatient treatment for these patients, when effective care 
can be provided in the ambulatory setting. These results need confirmation from other 
studies, because the 95% confidence intervals were wide. If confirmed, the high rate of IPH 
and ED use for all neurologic conditions and seizures/epilepsy by adolescents and young 
adults with FXS is worrisome because it suggests that the knowledge of the high prevalence 
of these conditions for people with FXS is not sufficient for primary care/ambulatory 
providers to prevent ED visits and IPHs, which are more intensive and expensive.
Finally, our fourth hypothesis, that the rate of hospital encounters for conditions not reported 
to be more prevalent among people with FXS is similar between people with FXS and the 
comparison group, was only partially confirmed. The conditions for which there was no 
difference when the comparison was made with young adults included all respiratory 
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conditions, genitourinary conditions, and gastroenteritis. The rate of hospital use for 
adolescents, compared to their age peers with FXS were elevated for all respiratory 
conditions (OR 1.9: 95% CI 1.1–3.4), genitourinary conditions (OR 5.1: 95% CI 2.1–12.7), 
and pneumonia (OR 6.2: 95% CI 1.8–21.0). Pneumonia hospitalizations were also higher for 
young adults with FXS (OR 4.8: 95% CI 1.1–20.6), compared to unaffected peers. The 
explanation for higher rates of hospitalization for these conditions was not revealed by this 
study, although it should be noted that the genitourinary condition result might be spurious 
because of the small sample size (less than 10 individuals in this group; Table 2). This 
finding suggests that there might be a disparity in the general access to primary/ambulatory 
care for adolescents with FXS. This is in keeping with our previous finding for certain 
common conditions among people with FXS, such as seizure disorders and epilepsy, for 
which primary care seems to be inadequate to prevent ED utilization and hospitalizations. 
The results may be at least partly attributable to sample size, as we had a relatively small 
number of individuals with FXS in our study.
We relied on secondary data to classify our cases and comparison groups; thus, the groups 
were not precise. We used all ICD9 codes under 299, meaning that all the codes 299.0–
299.9 were included. We could not identify all cases of FXS, as some people who refused 
genetic testing through DDSN were probably included in the ID or ASD group. In addition, 
when we could not distinguish the primary disabling condition, we classified people with 
both ID and ASD diagnoses in the ASD group. We did have service records from the DDSN 
and public school placements; thus, whenever ID or ASD services were recorded, we used 
the information to classify cases, but we acknowledge imprecision in the ID and ASD 
classification. This imprecision prevented us from specifying the severity of the condition. 
We acknowledge that children who first present with ASD prior to their FXS diagnosis are 
more likely to have a severe presentation of FXS; however, our data did not allow us to 
classify severity.
For the individuals in this population-based study, we had access to some potentially 
important confounding variables such as food stamp use (a proxy for socioeconomic status), 
attained level of education, placement in special education, and rural or urban county of 
residence. None of these variables contributed significantly in all of the GEE models shown 
in Table 2 and, in the case of county type, the direction was different for mental health visits 
as compared to all other ACSC visits. Living in a rural county increased the odds of having 
IPH/ED utilization for mental health conditions, and being in a rural county increased the 
odds of all other ACSC visits (results not shown in the table). We did not have access to 
other potential confounders, such as functional status, severity of the disability, and receipt 
of social- and health-related supports and services.
Our findings did not distinguish whether patients were experiencing substantial health 
problems that could not be treated in primary care, if they were not trying to access primary 
or outpatient specialty care, if they were having difficulty accessing ambulatory care, or 
whether there were gaps in the quality of care provided. In the case of seizures/epilepsy for 
people with FXS, the underlying condition might have required ED or IPH visits despite 
good outpatient care. We do not have data to address these concerns; thus, additional 
research, probably with a larger sample, is needed to better describe the factors influencing 
McDermott et al. Page 11













IPH and ED care and ACSC visits for mental illness, neurologic problems, and epilepsy/
seizures. Also, research on individuals with FXS and their primary care providers regarding 
potential barriers to early treatment is needed, as well as research on a wider age group. 
Clearly, our study focus on 15–24-year-olds limits our ability to describe the full range of 
events during young adulthood. We are only capturing the early years of adulthood, and the 
hospital utilization pattern might substantially change if the age group were expanded. 
Finally, quantitative research using systematic reviews of clinical records could assess the 
adequacy of care provided to individuals with FXS and identify areas that would improve it. 
Such reviews could lead to the development of new care guidelines that would be helpful in 
reducing the need for ACSC visits.
Overall, our finding that both adolescents and young adults with FXS, ASD, and ID had 
higher rates of hospital visits, when compared to people without these conditions, can be 
used to raise awareness among health care providers about efficacious treatment for 
seizures/epilepsy, other nervous system conditions, mental illness conditions, and 
genitourinary conditions in this relatively young age group in outpatient settings. We found 
that, for the study group with FXS, there were no conditions for which hospital use was 
statistically significantly increased during adulthood as compared to adolescence, suggesting 
that, in the dimension of hospital utilization at least, the transition from pediatric to adult 
care is occurring smoothly.
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Adjusted predicted probabilities from the fitted models of emergency department and 
inpatient stays by age, for those with FXS, ASD, ID, and comparison group. Note that the 
confounders are age group and its interactions with each of the three conditions, gender, 
food stamp use, grade 12 or higher attainment, placed in special education, the interaction 
between attaining grade 12 or higher and placed in special education, and urban/rural county 
type. FXS = fragile X syndrome; ASD = autism spectrum disorder; ID = intellectual 
disability.
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Adjusted predicted probabilities from the fitted models of visits by age, for those with FXS. 
Note that the confounders are gender, food stamp use, grade 12 attainment, placed in special 
education, the interaction between grade 12 attainment and special education placement, and 
urban/rural county type. FXS = fragile X syndrome; ACSC = ambulatory care sensitive 
conditions; ENT = ear, nose, and throat; UTI = urinary tract infection.
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Table 1
Distribution of the Number of Adolescents and Young Adults From South Carolina According to Condition 









Totalb 125 2,592 10,685 26,804
Sex
  Male 89 (71.2%) 1978 (76.3%) 6,220 (58.2%) 16,528 (61.7%)
  Female 36 (28.8%) 614 (23.7%) 4,465 (41.8%) 10,276 (38.3%)
Age groupc
  15–19 years 103 (82.4%) 2,283 (88.1%) 8,801 (82.4%) 22,063 (82.3%)
  20–24 years 88 (70.4%) 1,349 (52.0%) 6,629 (62.0%) 14,829 (55.3%)
Race
  Caucasian 65 (52.0%) 947 (36.5%) 3,204 (30.0%) -
  African American 35 (28.0%) 848 (32.7%) 5,961 (55.8%) -
  Other/Missing 25 (20.0%) 797 (30.8%) 1,520 (14.2%) -
County description
  Urban 85 (68.0%) 1,987 (76.7%) 7,303 (68.4%) 19,526 (72.9%)
  Rural 40 (32.0%) 605 (23.3%) 3,382 (31.6%) 7,278 (27.1%)
Food stamp use
  Yes 18 (14.4%) 390 (15.0%) 1,791 (16.8%) 690 (2.6%)
  No 107 (85.6%) 2,202 (85.0%) 8,894 (83.2%) 26,114 (97.4%)
Attained grade 12 or higher
  Yes 76 (60.8%) 1,604 (61.9%) 6,422 (60.1%) 21,001 (78.4%)
  No/Missing 49 (39.2%) 988 (38.1%) 4,263 (39.9%) 5,803 (21.6%)
Placed in special education
  Yes 112(89.6%) 2,374 (91.6%) 9,943 (93.1%) 2,426 (9.0%)
  No/Missing 13 (10.4%) 218 (8.4%) 742 (6.9%) 24,378 (91.0%)
a
Data retrieved from State Health Plan records, which did not record race.
b
Total = unduplicated number of persons with at least 1 full year of eligibility to Medicaid or State Health Plan.
c
Age groups sum to a number greater than overall total. Age category numbers are based on number of persons with at least 1 full year of 
eligibility in that age group. Therefore, individuals could be in both age categories.
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